FOCUSSED PROJECTS LTD

Comprehensive Financial Health Assessment: FOCUSSED PROJECTS LTD

1. Financial Health Score: B-

Explanation: The company exhibits a robust immune system in the form of healthy cash reserves and no immediate signs of insolvency. However, the financial medical history reveals a chronic condition: highly volatile equity levels that suggest episodic "bleeding" of value. The patient is stable and currently recovering well, but the underlying causes of its historical fluctuations need careful management to prevent future relapses.

2. Key Vital Signs

Interpretation of the company's core physiological metrics based on the latest financial year (ending 31 August 2025).

• Blood Pressure (Liquidity & Working Capital): Healthy but borderline. Current Assets stand at £8,924 against Current Liabilities of £6,230, yielding a Current Ratio of approximately 1.43:1. This indicates the company can comfortably meet its short-term debts, but the margin is not excessive. Net Current Assets (working capital) are £2,694, providing a reasonable financial cushion for daily operations.
• Hydration (Cash Reserves): Well-hydrated. Cash and cash equivalents total £8,343. For a micro-business, this represents a strong liquidity position, ensuring the company can cover immediate operational costs and respond to unexpected expenses without needing external life support.
• Body Mass (Net Assets & Equity): Recovering but historically volatile. Net Assets have grown to £6,785, up significantly from £3,783 in 2024 and a dangerously low £617 in 2023. While the current trajectory is positive, the overall "mass" remains lean for a company that has been trading for over two decades.
• Cholesterol (Debt Levels): Moderate. Total liabilities stand at £7,190 (including £960 in provisions). The company has a bank loan of £3,667 (split between current and non-current), alongside routine trade and tax creditors. The debt structure is manageable and does not suggest an over-reliance on external financing.

3. Symptoms Analysis & Diagnosis

What the financial data reveals about the underlying business health.

Symptoms of Note: 1. Episodic Weight Loss: The financial history displays a striking pattern of volatility. Net Assets oscillated wildly—dropping from a healthy £9,185 in 2019 to a critically low £275 in 2021, recovering to £7,087 in 2022, crashing again to £617 in 2023, and now recovering once more. In a medical context, this cyclical weight loss and gain suggests either an intensive, project-based income cycle (feast or famine) or deliberate extraction of value by the sole director in the form of dividends. 2. Asset Restructuring: The latest accounts show the disposal of a motor vehicle and the acquisition of new equipment/computer assets. The business is actively renewing its physical tools, which is a positive sign of investment, but it also indicates a shift in operational capacity. 3. Lean Operational Structure: As a micro-entity with a single director/employee, the business operates with minimal overhead (trade creditors are a mere £853). This keeps the patient agile but vulnerable to any disruption in the director's capacity to work.

Diagnosis: FOCUSSED PROJECTS LTD is a stable but highly cyclical micro-enterprise. The business is not in financial distress; rather, it appears to suffer from "lumpy" financial cycles typical of project-based consulting or support services. The dramatic drops in net assets in previous years were likely caused by significant drawings/dividends taken by the director after profitable periods, rather than trading losses. The most recent period shows a healthy injection of retained earnings, rebuilding the company's equity base after the significant depletion seen in 2023.

4. Prognosis & Recommendations

Future financial outlook and specific actions to improve financial wellness.

Prognosis: The short-term outlook is positive. The company has strong cash reserves, manageable debt, and has successfully rebuilt its equity base in the last financial year. However, the long-term prognosis is contingent on the director's ability to smooth out the extreme fluctuations in net assets. If the historical pattern repeats, we may see another significant drop in equity in the coming years as profits are extracted.

Recommendations for Financial Wellness:

1. Build a Financial Immune Buffer: While the current cash position is healthy, the volatile history suggests the company is prone to rapid equity depletion. I recommend establishing a minimum retained earnings floor (e.g., £5,000) that is not distributed as dividends. This acts as a financial vaccine against future operational shocks.
2. Monitor Debt Service: The bank loan (£3,667) is currently manageable, but any additional borrowing should be carefully weighed against the company's lean asset base. Ensure that the cash flow generated by the new equipment is sufficient to service this debt without stressing the working capital.
3. Diversify Income Streams: Given the apparent "feast or famine" cycle, the business should explore ways to create more recurring, retainer-based revenue. This will help stabilize the vital signs and prevent the severe "weight loss" episodes seen in 2021 and 2023.
4. Regular Financial Check-ups: The director should maintain strict discipline in monitoring cash flow against the cyclicality of the business to ensure that dividend extractions do not leave the company dangerously thin, as occurred in 2023 when net assets fell to just £617.